{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:22:50Z","timestamp":1794082970798,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.survophthal.2025.08.017","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:20:38Z","timestamp":1756434038000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A narrative review of the psychological impact of intravitreal injections"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2617-1614","authenticated-orcid":false,"given":"Nicholas George","family":"Giannopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo Zak","family":"Macri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isuri Apsara Kumari","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Tian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Onn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.survophthal.2025.08.017_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/eye.2016.18","article-title":"Determining patient preferences in the management of neovascular age-related macular degeneration: a conjoint analysis","volume":"30","author":"Baxter","year":"2016","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.017_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13548506.2014.936886","article-title":"Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review","volume":"20","author":"Boyle","year":"2014","journal-title":"Psychol Health Med"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13548506.2016.1274040","article-title":"Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration","volume":"23","author":"Boyle","year":"2018","journal-title":"Psychol Health Med"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.017_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/09286586.2021.1955390","article-title":"Effect of music selection on anxiety level during intravitreal injections for individuals of varying cultures","volume":"29","author":"Brosh","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.017_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40123-023-00879-7","article-title":"Effect of needle gauge size on pain during intravitreal anti-VEGF injection: a systematic review and network meta-analysis","volume":"13","author":"Butler","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2025.08.017_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9120235","article-title":"Effect of music on patient experience during intravitreal injection","volume":"2020","author":"Chan","year":"2020","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41433-022-02221-0","article-title":"Chair RETIARETINASG. Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?","volume":"37","author":"Chaudhary","year":"2022","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/jop.2011.0257","article-title":"Effects of music therapy on intravitreal injections: a randomized clinical trial","volume":"28","author":"Chen","year":"2012","journal-title":"J Ocul Pharm Ther"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.017_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archophthalmol.2009.139","article-title":"Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration","volume":"127","author":"Chua","year":"2009","journal-title":"AMA Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.017_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/eye.2014.69","article-title":"Implementation of a nurse-delivered intravitreal injection service","volume":"28","author":"DaCosta","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2025.08.017_bib11","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2147\/OPTH.S273564","article-title":"Patient preferences associated with anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration and diabetic macular edema","volume":"14","author":"Davis","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.017_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00417-013-2412-6","article-title":"Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration \u2014 monthly injections versus pro re nata","volume":"252","author":"Droege","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.017_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00592-020-01513-9","article-title":"Expectations and fears of patients with diabetes and macular edema treated by intravitreal injections","volume":"57","author":"Fajnkuchen","year":"2020","journal-title":"Acta Diabetol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.017_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.oftal.2021.02.005","article-title":"Assessment of the perception of healthcare barriers and the impact of intravitreal injections on neovascular age-related macular degeneration","volume":"97","author":"Fern\u00e1ndez-Vigo","year":"2022","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2025.08.017_bib16","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.jval.2021.04.1113","article-title":"PSS12 understanding the patient experience with anti-VEGF intravitreal injections and the impact on treatment maintenance: a qualitative interview study","volume":"24","author":"Giocanti-Aur\u00e9gan","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40123-016-0058-2","article-title":"Strategies for improving patient comfort during intravitreal injections: results from a survey-based study","volume":"5","author":"Gomez","year":"2016","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.017_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12968\/bjon.2017.26.12.678","article-title":"Intravitreal injections service: a patient experience evaluation","volume":"26","author":"Hasan","year":"2017","journal-title":"Br J Nurs"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib19","doi-asserted-by":"crossref","DOI":"10.12968\/ijop.2010.1.2.68","article-title":"Patient experience of intravitreal injections in AMD","volume":"1","author":"Henriksen","year":"2010","journal-title":"Int J Ophthalmic Pract"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.017_bib20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/a-1473-5713","article-title":"The challenges of treating neovascular age-related macular degeneration","volume":"239","author":"Hollaus","year":"2022","journal-title":"Klin Monbl Augenheilkd"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.017_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/joco.joco_6_21","article-title":"Factors associated with pain level in patients receiving intravitreal injection","volume":"33","author":"\u0130naltekin","year":"2021","journal-title":"J Curr Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.017_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12325-022-02052-1","article-title":"Mental status and feasibility of an intravitreal ranibizumab treat-and-extend regimen in patients with neovascular age-related macular degeneration","volume":"39","author":"Kato","year":"2022","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478993","article-title":"State and trait anxiety scores of patients receiving intravitreal injections","volume":"2","author":"Kayikcioglu","year":"2017","journal-title":"Biomed Hub"},{"key":"10.1016\/j.survophthal.2025.08.017_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.iae.0000236481.40056.25","article-title":"Prefilled syringe needles versus standard removable needles for intravitreous injection","volume":"26","author":"Kozak","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.08.017_bib25","article-title":"Treat-and-extend vs. Pro re nata regimen of ranibizumab for diabetic macular edema-a two-year matched comparative study","volume":"8","author":"Lai","year":"2021","journal-title":"Front Med"},{"issue":"9827","key":"10.1016\/j.survophthal.2025.08.017_bib26","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.017_bib27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00417-020-04699-4","article-title":"Feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections","volume":"258","author":"Martel","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.017_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000669","article-title":"Questionnaire to assess life impact of treatment by intravitreal injections (QUALITII): development of a patient-reported measure to assess treatment burden of repeat intravitreal injections","volume":"6","author":"McClard","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4103\/ijo.IJO_1269_20","article-title":"Subjective and objective measures of the patient experience before, during, and after intravitreal anti-vascular endothelial growth factor injections","volume":"69","author":"Mekala","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib30","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ophtha.2015.12.001","article-title":"Patient preferences in the treatment of neovascular age-related macular degeneration: a discrete choice experiment","volume":"123","author":"Mueller","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/jovr.jovr_50_18","article-title":"Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: clinical practice guideline","volume":"13","author":"Nikkhah","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2025.08.017_bib32","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.017_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bjo.2004.048637","article-title":"Randomised controlled trial of preoperative information to improve satisfaction with cataract surgery","volume":"89","author":"Pager","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.017_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2019.02.005","article-title":"Randomized trial of treat and extend ranibizumab with and without navigated laser versus monthly dosing for diabetic macular edema: TREX-DME 2-year outcomes","volume":"202","author":"Payne","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.017_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4274\/tjo.28003","article-title":"Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration","volume":"47","author":"Polat","year":"2017","journal-title":"Turk J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.017_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/bjophthalmol-2015-307249","article-title":"Ranibizumab 0.5\u2005mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study","volume":"100","author":"Pr\u00fcnte","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.017_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.eye.6702577","article-title":"Scleral penetration force requirements for commonly used intravitreal needles","volume":"21","author":"Pulido","year":"2006","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.017_bib38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4103\/ijo.IJO_2043_19","article-title":"Eyelid retraction discomfort with cotton-tipped applicator, unimanual and speculum intravitreal injection techniques: eyelid retraction technique randomized comparison trial (Eyelid RETRACT)","volume":"68","author":"Raevis","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.017_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ajo.2006.03.042","article-title":"Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection","volume":"142","author":"Roth","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00417-021-05308-8","article-title":"Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (Mercury)","volume":"260","author":"Sakamoto","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/aos.12802","article-title":"Anxiety levels and perceived pain intensity during intravitreal injections","volume":"94","author":"Segal","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.017_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2017.03.005","article-title":"Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration","volume":"177","author":"Senra","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.017_bib43","article-title":"The value of handholding during intravitreal injections","author":"Shaughnessy","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.survophthal.2025.08.017_bib44","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/OPTH.S185052","article-title":"The burden of neovascular age-related macular degeneration: a patient's perspective","volume":"12","author":"Spooner","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.017_bib45","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/OPTH.S24358","article-title":"Narendran N. Evaluation of patients\u2019 experiences at different stages of the intravitreal injection procedure \u2013 what can be improved?","volume":"5","author":"Tailor","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.017_bib46","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/s41433-020-0920-2","article-title":"Design, implementation, and evaluation of a nurse-led intravitreal injection programme for retinal diseases in Singapore","volume":"34","author":"Teo","year":"2020","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.017_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0264619613481778","article-title":"Living with age-related macular degeneration treatment: patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections","volume":"31","author":"Thetford","year":"2013","journal-title":"Brit J Vis Impa"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.017_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/09273948.2013.801988","article-title":"Bacterial contamination of needles used for intravitreal injections: comparison between 27-gauge and 30-gauge needles","volume":"21","author":"Tufan","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.017_bib49","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1111\/aos.12417","article-title":"Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration","volume":"92","author":"Vaze","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.017_bib50","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00417-021-05422-7","article-title":"Anxiety and pain perception using a speculum-free eyelid retraction technique for intravitreal injection","volume":"260","author":"Wasser","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.017_bib51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3928\/23258160-20210819-02","article-title":"Impact of anxiety levels and sleep patterns on perceived pain during intravitreal bevacizumab injections","volume":"52","author":"Wieder","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retin"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:28:39Z","timestamp":1778945319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0039625725001444"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.017","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A narrative review of the psychological impact of intravitreal injections","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}